Published in PLoS One on November 16, 2012
Medication safety research by observational study design. Int J Clin Pharm (2016) 0.77
Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review. BMC Med Res Methodol (2017) 0.75
Self-controlled case-series study to verify the effect of adherence to Beta-blockers in secondary prevention of myocardial infarction. J Am Heart Assoc (2015) 0.75
Risk of Gastrointestinal Bleeding Among Dabigatran Users - A Self Controlled Case Series Analysis. Sci Rep (2017) 0.75
The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol (1991) 12.76
Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med (1994) 6.50
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77
Should we use a case-crossover design? Annu Rev Public Health (2000) 4.32
Tutorial in biostatistics: the self-controlled case series method. Stat Med (2006) 4.12
Limitations of the case-only design for identifying gene-environment interactions. Am J Epidemiol (2001) 2.97
Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol (1996) 2.65
Relative incidence estimation from case series for vaccine safety evaluation. Biometrics (1995) 2.55
Confounding and exposure trends in case-crossover and case-time-control designs. Epidemiology (1996) 2.40
Estimation of vaccine effectiveness using the screening method. Int J Epidemiol (1993) 1.86
The case-time-control design. Epidemiology (1995) 1.55
Overlap bias in the case-crossover design, with application to air pollution exposures. Stat Med (2005) 1.48
When should case-only designs be used for safety monitoring of medical products? Pharmacoepidemiol Drug Saf (2012) 1.45
Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics (2008) 1.43
Control without separate controls: evaluation of vaccine safety using case-only methods. Vaccine (2004) 1.32
Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf (1997) 1.20
'Why me?' versus 'why now?'--differences between operational hypotheses in case-control versus case-crossover studies. Pharmacoepidemiol Drug Saf (2007) 1.19
Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations. Stat Med (1988) 1.01
Sample sizes for self-controlled case series studies. Stat Med (2006) 1.00
Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice. Epidemiol Infect (2011) 0.96
Within-subject exposure dependency in case-crossover studies. Stat Med (2001) 0.92
The use of primary care databases: case-control and case-only designs. Fam Pract (2006) 0.92
A modified self-controlled case series method to examine association between multidose vaccinations and death. Stat Med (2010) 0.89
Comparison of the statistical efficiency of case-crossover and case-control designs: application to severe cutaneous adverse reactions. J Clin Epidemiol (2001) 0.87
Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Stat Med (2010) 0.85
Use of the self-controlled case series method in drug safety assessment. Expert Opin Drug Saf (2011) 0.81
[Case crossover studies: a conceptual and methodological approach]. Gac Med Mex (2010) 0.77
[Case-crossover design: Basic essentials and applications]. Gac Sanit (2009) 0.77
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet (2010) 7.61
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J (2003) 6.88
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med (2014) 5.98
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA (2010) 4.56
Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med (2009) 4.19
Public availability of results of trials assessing cancer drugs in the United States. J Clin Oncol (2013) 3.73
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med (2008) 3.63
Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort study. PLoS Med (2012) 3.33
Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA (2013) 2.97
Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J (2005) 2.83
Quality of reporting of noninferiority and equivalence randomized trials. JAMA (2006) 2.79
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis Rheum (2010) 2.68
Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med (2011) 2.62
Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med (2010) 2.52
What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J (2007) 2.52
Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures. Ann Surg (2014) 2.48
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum (2004) 2.44
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment. Arthritis Rheum (2008) 2.41
High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe. J Clin Oncol (2005) 2.35
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev (2012) 2.31
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis (2009) 2.20
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Evid Based Child Health (2013) 2.12
Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet (2008) 2.03
Lack of head-to-head trials and fair control arms: randomized controlled trials of biologic treatment for rheumatoid arthritis. Arch Intern Med (2012) 1.95
The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: a systematic review. Ann Surg (2006) 1.91
Splint for base-of-thumb osteoarthritis: a randomized trial. Ann Intern Med (2009) 1.86
Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS One (2010) 1.86
Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 1.82
Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med (2011) 1.82
Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLoS Med (2013) 1.78
Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med (2007) 1.77
General practitioners' fear-avoidance beliefs influence their management of patients with low back pain. Pain (2006) 1.77
Reporting of sample size calculation in randomised controlled trials: review. BMJ (2009) 1.76
Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen. Intensive Care Med (2014) 1.76
A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol (2005) 1.74
Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS (2004) 1.73
Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials. J Clin Epidemiol (2004) 1.71
Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis (2012) 1.67
The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort. J Rheumatol (2009) 1.59
Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. JAMA (2003) 1.58
Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 1.57
Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial. J Rheumatol (2007) 1.57
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Cochrane Database Syst Rev (2014) 1.56
Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. Eur Heart J (2010) 1.53
Bacteremia in patients receiving TNF-alpha antagonists--a prospective multicenter study. J Infect (2013) 1.52
Beneficial effects of information leaflets before spinal steroid injection. Joint Bone Spine (2002) 1.51
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective. Clin Chem Lab Med (2015) 1.48
Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants. BMC Med (2012) 1.46
Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon study. Contemp Clin Trials (2010) 1.46
The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine (2007) 1.44
Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. J Rheumatol (2013) 1.42
Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry. Clin Exp Rheumatol (2012) 1.42
Missing data in randomized controlled trials of rheumatoid arthritis with radiographic outcomes: a simulation study. Arthritis Rheum (2008) 1.40
Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy. Ann Rheum Dis (2012) 1.39
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis (2011) 1.37
Predictive factors of early postoperative urinary retention in the postanesthesia care unit. Anesth Analg (2005) 1.36
Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. J Rheumatol (2007) 1.33
Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis. Ann Intern Med (2009) 1.31
Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review. PLoS Med (2006) 1.31
Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review. Am J Med Sci (2007) 1.31
Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS (2007) 1.28
Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study. BMJ (2012) 1.28
Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. Eur J Prev Cardiol (2011) 1.25
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med (2010) 1.24
Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med (2012) 1.23
Influence of blinding sequence of radiographs on the reproducibility and sensitivity to change of joint space width measurement in knee osteoarthritis. Arthritis Care Res (Hoboken) (2010) 1.23
Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review. BMJ (2013) 1.22
Preventing bias in cluster randomised trials. PLoS Med (2009) 1.22
Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ (2013) 1.21
Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation (2009) 1.21
Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed. J Clin Epidemiol (2010) 1.21
Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries. Rheumatology (Oxford) (2011) 1.20
Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues. J Rheumatol (2005) 1.19
A priori postulated and real power in cluster randomized trials: mind the gap. BMC Med Res Methodol (2005) 1.19
Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. CMAJ (2013) 1.19
Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis (2012) 1.14
Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials. Ann Intern Med (2016) 1.14
Use of trial register information during the peer review process. PLoS One (2013) 1.13
Validation of a short form of the Western Ontario and McMaster Universities Osteoarthritis Index function subscale in hip and knee osteoarthritis. Arthritis Rheum (2007) 1.12
Feeling good rather than feeling better matters more to patients. Arthritis Rheum (2006) 1.11
Reporting of results from network meta-analyses: methodological systematic review. BMJ (2014) 1.11
Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: results from a randomized control study. Arthritis Rheum (2009) 1.10
Aortic event rate in the Marfan population: a cohort study. Circulation (2011) 1.09
A review of blinding in randomized controlled trials found results inconsistent and questionable. J Clin Epidemiol (2005) 1.09
Peer review of grant applications: criteria used and qualitative study of reviewer practices. PLoS One (2012) 1.09
Amyloid arthropathy in the course of multiple myeloma. J Rheumatol (2002) 1.08
The methods for handling missing data in clinical trials influence sample size requirements. J Clin Epidemiol (2004) 1.08
Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome. Arch Cardiovasc Dis (2010) 1.08